Temporality of change in Ki67 labelling following neoadjuvant systemic chemotherapy of breast cancer—the common drop often subsides with time
Ki67 immunohistochemistry is widely used in clinical settings to assess tumour proliferation in breast cancer, yet the temporal changes in Ki67 labelling index following neoadjuvant chemotherapy (NACT) are underexplored. Matched core biopsy and surgical excision specimens of invasive breast cancers...
Elmentve itt :
| Szerzők: |
Ferenczi Ádám Lantos Tamás Cserni Gábor |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2025
|
| Sorozat: | VIRCHOWS ARCHIV
|
| Tárgyszavak: | |
| doi: | 10.1007/s00428-025-04263-7 |
| mtmt: | 36433064 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/39146 |
Hasonló tételek
-
The effects of neoadjuvant chemotherapy on grade and proliferation of breast cancer
Szerző: Ferenczi Ádám
Megjelent: (2026) -
Different Methods of Pretreatment Ki-67 Labeling Index Evaluation in Core Biopsies of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Their Relation to Response to Therapy
Szerző: Vörös András, et al.
Megjelent: (2015) -
The prognostic value of histological grade determined after neoadjuvant chemotherapy of breast cancer
Szerző: Zombori Tamás, et al.
Megjelent: (2025) -
Changes in breast cancer grade from biopsy to excision following surgery or primary chemotherapy
Szerző: Ferenczi Ádám, et al.
Megjelent: (2024) -
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
Szerző: Nikolényi Alíz, et al.
Megjelent: (2011)